Učitavanje...
Myeloid cells as target of fingolimod action in multiple sclerosis
OBJECTIVE: To track the effects of fingolimod, an approved drug for multiple sclerosis (MS), on the activation of myeloid cells from the periphery to the CNS. METHODS: In vitro and ex vivo immunologic studies coupled with flow cytometry were performed to evaluate the action of fingolimod on lipopoly...
Spremljeno u:
| Izdano u: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Glavni autori: | , , , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Lippincott Williams & Wilkins
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4635549/ https://ncbi.nlm.nih.gov/pubmed/26587553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000157 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|